Legend Biotech (LEGN) Consolidated Net Income (2019 - 2025)

Legend Biotech has reported Consolidated Net Income for 7 years, with the latest figure at $30.8 million in Q4 2025.

• For the quarter ending Q4 2025, Consolidated Net Income fell 43.69% year-over-year to $30.8 million; the trailing twelve-month figure through Dec 2025 stood at -$229.2 million (down 64.58% YoY), and the FY2025 full-year result was -$268.4 million, down 251.64% from the prior year.
• Consolidated Net Income for Q4 2025 stood at $30.8 million, up from -$38.5 million in the prior quarter.
• The five-year high for Consolidated Net Income was $54.7 million in Q4 2024, with the low at -$198.5 million in Q2 2023.
• Historically, Consolidated Net Income has averaged -$81.9 million across 5 years, with a median of -$90.0 million in 2021.
• Annual changes were most pronounced in 2022 — Consolidated Net Income sank 33686.45% — and 2024, when it jumped 137.26%.
• Legend Biotech's Consolidated Net Income stood at -$88.3 million in 2021, then sank by 53.47% to -$135.6 million in 2022, then decreased by 8.29% to -$146.8 million in 2023, then jumped by 137.26% to $54.7 million in 2024, then slumped by 43.69% to $30.8 million in 2025.
• The last three Consolidated Net Income figures came in at $30.8 million (Q4 2025), -$38.5 million (Q3 2025), and -$124.2 million (Q2 2025), per Business Quant data.